| Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725) |
|---|
| 07/21/1999 | EP0930331A2 Bioactive and hydrophylic coating of polymeric substrates |
| 07/21/1999 | EP0929325A1 ePTFE SMALL CALIBER VASCULAR GRAFTS WITH SIGNIFICANT PATENCY ENHANCEMENT VIA A SURFACE COATING WHICH CONTAINS COVALENTLY BONDED HEPARIN |
| 07/21/1999 | EP0929324A1 Process for preparing polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
| 07/21/1999 | CN1223149A Thermosol dot type adhesive plaster and thermal melting device thereof |
| 07/20/1999 | US5925552 Method for attachment of biomolecules to medical devices surfaces |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/14/1999 | EP0928612A2 A method for treating a prosthesis having an apertured structure and associated devices |
| 07/14/1999 | EP0807141B1 Process for modifying surfaces |
| 07/14/1999 | CA2259073A1 Bioactive and hydrophilic coating of polymeric substrates |
| 07/13/1999 | US5922690 Having at least 2 sulfate groups per disaccharide obtained by chemical sulfation of native dermatan sulfate. |
| 07/13/1999 | US5922322 Cleaves at the gamma glycine404-alanine405 peptide bond; apply to medical equipment to inhibit thrombus formation; administering to treat restenosis post-surgery, to inhibit vascular reocclusion |
| 07/08/1999 | WO1999033499A2 Attachment of biomolecules to medical device surfaces |
| 07/07/1999 | EP0927222A1 Thermoplastic polyurethanes containing active substances |
| 07/07/1999 | EP0528039B1 Stent for vessel, structure of holding said stent, and device for mounting said stent |
| 07/06/1999 | US5919223 Graphite impregnated prosthetic vascular graft materials |
| 07/01/1999 | WO1999032080A2 Device for targeted immobilization of the thrombogenic inhibitor hirudine on polymer surfaces |
| 07/01/1999 | DE19857904A1 Verfahren zur gezielten Immobilisierung des Thrombogeneseinhibitors Hirudin auf Polymeroberflächen Method for the selective immobilization of Thrombogeneseinhibitors hirudin on polymer surfaces |
| 06/30/1999 | EP0925826A1 Use of a neutral or cationic polymer for preventing the activation of blood or plasma contact phase in contact with a semipermeable membrane |
| 06/30/1999 | CN1221359A Molecular tailoring of surfaces |
| 06/23/1999 | EP0924061A1 Latex article |
| 06/23/1999 | EP0923953A2 Drug coating with topcoat |
| 06/23/1999 | EP0923390A1 Method for making improved heparinized biomaterials |
| 06/23/1999 | EP0923387A2 Heparinized medical devices containing heparin-binding growth factor conjugates |
| 06/22/1999 | US5914115 Surface treated by glow discharge in the presence of reactive gas to provide plurality of reactive functional groups on surface and an antithrombogenic agent bound thereto |
| 06/17/1999 | WO1999016477A3 32p-polyphosphazene |
| 06/10/1999 | WO1999027976A1 Non thrombogenic polymers with compatibility with organic fluids and tissues |
| 06/10/1999 | WO1999027968A2 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices |
| 06/09/1999 | EP0921139A1 Modified polymers containing poly(2-hydroxyethyl (meth)acrylate) segment in the molecule |
| 06/09/1999 | EP0920342A2 Medical device for delivering a therapeutic substance |
| 06/08/1999 | CA1340585C Medical instrument and method for fabricating same |
| 06/03/1999 | WO1999026983A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 06/02/1999 | EP0531547B1 Composite artificial blood vessel |
| 06/02/1999 | CN1218488A Zeolite in packaging film |
| 06/01/1999 | US5908449 Blood contact surfaces using extracellular matrix synthesized in vitro |
| 05/27/1999 | WO1998058680A3 Stents coated with fluoroalkyl groups |
| 05/26/1999 | CN1217664A Covalent modification of surfaces with polymers to increase biocompatibility |
| 05/25/1999 | US5906824 Substrate; irradiating biopolymer; tackiness to cells but not blood platelets |
| 05/20/1999 | WO1999024106A1 Intravesical infuser |
| 05/20/1999 | CA2308150A1 Intravesical infuser |
| 05/12/1999 | EP0914834A2 Anti-thrombogenic polyurethane-hydrophilic polymer blend |
| 05/12/1999 | EP0914348A1 Polymers for delivering nitric oxide in vivo |
| 05/11/1999 | US5902799 Methods of modulating tissue growth and regeneration |
| 05/11/1999 | US5902608 Platelets adhered to a solid substrate that upon reconstitution adhere and spread and form a hemostatic plug to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces, and release platelet-derived growth factor |
| 05/11/1999 | US5902283 Implantable medical device |
| 05/06/1999 | WO1999008717A3 Latent reactive polymers with biologically active moieties |
| 05/06/1999 | EP0913416A1 Biocompatible polymers |
| 04/22/1999 | WO1999019381A1 Medical material containing fluorinated polysulfone having excellent antithrombotic activity |
| 04/15/1999 | WO1998057671A3 Polycarbonate-polyurethane dispersions for thrombo-resistant coatings |
| 04/15/1999 | DE19743373A1 ·3··2·P-Polyphosphazen · 3 · · 2 · P-polyphosphazene |
| 04/14/1999 | EP0626983B1 Polymeric blends with zwitterionic groups |
| 04/08/1999 | WO1999016477A2 32p-polyphosphazene |
| 04/08/1999 | WO1999016475A2 Process for preparing biologically compatible polymers and their use in medical devices |
| 04/06/1999 | US5891507 Stent contains longitudinal openings |
| 04/06/1999 | US5891506 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices |
| 04/06/1999 | US5891196 Method for actively binding heparin to crosslinked biological tissues |
| 04/06/1999 | US5891192 Ion-implanted protein-coated intralumenal implants |
| 04/06/1999 | US5891109 Medical device and production thereof |
| 03/31/1999 | EP0904157A1 Molecular tailoring of surfaces |
| 03/31/1999 | EP0637309B1 Metal coatings |
| 03/23/1999 | US5885647 Crosslinking polyamine with oxidized heparin, heparin sulfte or chondroitin sulfate |
| 03/23/1999 | US5885609 Biocompatible articles and method for making same |
| 03/18/1999 | WO1998058690A3 Adherent, flexible hydrogel and medicated coatings |
| 03/11/1999 | WO1998057680A3 Medical device for delivering a therapeutic substance |
| 03/10/1999 | EP0900092A1 Pentosanpolysulfate coating for medical devices |
| 03/09/1999 | US5879383 Blood contact surfaces using endothelium on a subendothelial matrix |
| 03/04/1999 | WO1998055162A3 Treating metal surfaces to enhance bio-compatibility |
| 03/04/1999 | DE19839996A1 Modification of antifriction property of polymer surface |
| 03/02/1999 | US5877263 Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
| 03/02/1999 | US5876753 Plasma deposition of functional groups onto surface; immersion in solution |
| 03/02/1999 | US5876433 Stent and method of varying amounts of heparin coated thereon to control treatment |
| 02/25/1999 | WO1999008717A2 Latent reactive polymers with biologically active moieties |
| 02/23/1999 | US5874500 Crosslinked polymer compositions and methods for their use |
| 02/23/1999 | US5874419 Compositions and methods for modulating growth of a tissue in a mammal |
| 02/23/1999 | US5873904 Silver implantable medical device |
| 02/18/1999 | WO1998050086A3 Medical devices containing segmented polyurethane biomaterials |
| 02/17/1999 | EP0896600A1 Non-thrombogenic and anti-thrombogenic polymers |
| 02/04/1999 | DE19732774A1 Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters |
| 02/03/1999 | EP0894813A1 Non cytotoxic medical polyurethane articles |
| 02/02/1999 | US5866113 Medical device with biomolecule-coated surface graft matrix |
| 02/02/1999 | US5865814 Blood contacting medical device and method |
| 01/26/1999 | US5863654 Polypropylene having a coating of carbon made from the dehydrochlorination of a graft polymer of the polypropylene and vinylidene chloride |
| 01/21/1999 | DE19730296A1 Implant for use in the body, e.g. heart flap |
| 01/20/1999 | EP0891998A1 Graft polymers |
| 01/14/1999 | WO1999001167A1 Process for modifiying surfaces using the reaction product of a water-insoluble polymer and a polyalklene imine |
| 01/14/1999 | WO1999001089A1 Implantable prosthetic devices coated with bioactive molecules |
| 01/14/1999 | DE19718430A1 Anti=infective treatment of bio=material, e.g. prosthesis |
| 01/14/1999 | CA2301064A1 Implantable prosthetic devices coated with bioactive molecules |
| 01/13/1999 | EP0890367A2 Urologic implant, especially support for the vascular walls of the urinal tract |
| 01/13/1999 | EP0697896B1 Modification of implant surface with bioactive conjugates for improved integration |
| 01/07/1999 | WO1999000070A1 Medical device for in vivo nitric oxide release |
| 01/07/1999 | CA2294425A1 Medical device for in vivo nitric oxide release |
| 01/05/1999 | US5855618 Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
| 01/05/1999 | CA2045640C Receptor membranes and ionophore gating |
| 12/30/1998 | WO1998058690A2 Adherent, flexible hydrogel and medicated coatings |
| 12/30/1998 | WO1998058680A2 Stents coated with fluoroalkyl groups |
| 12/30/1998 | EP0887356A1 Bactericidal, blood compatible, NCO-reactive modified copolymer |
| 12/30/1998 | CA2294872A1 Stents that are coated with fluoroalkyl groups, processes for their production and their use for restenosis prophylaxis |
| 12/30/1998 | CA2293370A1 Adherent, flexible hydrogel and medicated coatings |
| 12/24/1998 | CA2241380A1 Blood-compatible and bacteria-repellent nco-reactively modified copolymer |